Headache and seizure on postpartum day 7: late postpartum eclampsia: a case report
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20231584Keywords:
Late postpartum eclampsia, Gestational hypertension, Pre-eclampsia, Eclampsia, Seizures, Hypertension, Pregnancy, Magnesium sulphate, Maternal death, Cerebral venous thrombosis, Cerebral venogramAbstract
Historically, convulsions beginning more than 48 hours, but less than 4 weeks, after delivery, known as late postpartum eclampsia, was thought to be uncommon; however, recent evidence suggests that its incidence is increasing. In addition, the presentation of late postpartum preeclampsia-eclampsia may differ from that occurring during the pregnancy. About 40% of late eclampsia has no premonitory symptoms. This contributes to difficulty in diagnosing late postpartum preeclampsia-eclampsia in an emergency department setting. Greater awareness and knowledge of this disorder by ED physicians should improve outcomes in these potentially life-threatening cases. The authors present a case of new-onset seizures occurring 07 days postpartum. The patient presented with headache, hypertension, and generalized tonic-clonic seizures to the emergency department. Postpartum eclampsia was diagnosed and IV magnesium sulphate was administered. The patient had no further seizures and did not require long-term anticonvulsants.
Metrics
References
World Health Organization. Trends in maternal mortality: 1990 to 2015 Estimates by WHO, UNICEF, UNFPA, The World Bank and the United Nations Population Division. Geneva. 2015. Available at: http://apps.who.int/iris/bitstream/10665/194254/1/9789241565141_eng.pdf?ua=1. Accessed on 06 March 2023.
Say L, Chou D, Gemmill A, Tunçalp Ö, Moller A-B, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323-33.
Knight M, Nair M, Tuffnell D, Kenyon S, Shakespeare J, Brocklehurst P, et al. Saving lives, improving mothers’ care—surveillance of maternal deaths in the UK 2012-14 and lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009-14. Oxford: Nuffield Department of Population Health. 2016.
Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens. 2014;4(2):97-104.
Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):1-7.
Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M, Vogel JP, et al. Pre‐eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014;121(1):14-24.
Giordano JC, Parpinelli MA, Cecatti JG, Haddad SM, Costa ML, Surita FG, et al. The burden of eclampsia: results from a multicenter study on surveillance of severe maternal morbidity in Brazil. PLoS One. 2014;9(5):e97401.
Duley L, Gülmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2010;11:CD000025.
World Health Organization. WHO model list of essential medicines. Geneva: World Health Organization. 2017. Available at: https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/essential-medicines-lists. Accessed on 06 March 2023.
Koopmans CM, Bijlenga D, Groen H, Vijgen SM, Aarnoudse JG, Bekedam DJ, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374(9694):979-88.
Ronsmans C, Campbell O. Quantifying the fall in mortality associated with interventions related to hypertensive diseases of pregnancy. BMC Pub Health. 2011;11(3):S8.
Lubarsky SL, Barton JR, Friedman SA, Nasreddine S, Ramadan MK, Sibai BM. Late postpartum eclampsia revisited. Obstet Gynecol. 1994;83(4):502-5.
Douglas KA, Redman CWG. Eclampsia in the United Kingdom. BMJ. 1994;309:1395-400.
Leitch CR, Cameron AD, Walker JJ. The changing pattern of eclampsia over a 60-year period. Br J Obstet Gynaecol. 1997;104:917-22.
Matthys LA, Coppage KH, Lambers DS, Barton JR, Sibai BM. Delayed postpartum preeclampsia: an experience of 151 cases. Am J Obstet Gynecol 2004;190:1464-6.
Chames MC, Livingston JC, Ivestor TS, Barton JR, Sibai BM. Late postpartum eclampsia: a preventable disease? Am J Obstet Gynecol 2002;186:1174-7.
Lubrasky SL, Barton JR, Freidman SA, Sibai BM. Late postpartum eclampsia revisited. Obstet Gynaecol. 1994;83:502-5.
Veltkamp R, Kupsch A, Polasek J, Pfister HW. Late onset postpartum eclampsia without preeclamptic prodromi: clinical and neuroradiological presentation in two patients. J Neurol Neurosurg Psychiatry. 2000;69:824-7.
Felz MW, Barnes DB, Figueroa RE. Late postpartum eclampsia 16 days after delivery: case report with clinical radiologic and pathophysiologic correlations. J Am Board Fam Pract. 2000;13:39-46.
Khadra M, Cooper J, Singh J. Raising awareness of postpartum seizures. J Obst Gynaecol. 2003;23:201-2.
Hinchey J, Chaves C, Appignani B, Mas JL, Caplan LR. A reversible posterior leukoencephlopathy syndrome. N Engl J Med. 1996;334:494-500.
Duley L. Magnesium sulphate in eclampsia. Eclampsia Trial Collaborative Group. Lancet. 1998;352:67-8.
Hirshfeld-Cytron J, Lam C, Karumanchi SA. Late postpartum eclampsia: examples and review. Obstet Gynecol Surv. 2006;61:471-80.
Magee LA, Helewa M, Moutquin J-M. Diagnosis, evaluation and management of the hypertensive disorders of pregnancy J Obstet Gynaecol Can. 2008;30(3):S1-S48.
Downloads
Published
How to Cite
Issue
Section
